Molecular Testing in Cancer
Molecular Testing in Cancer
Cancer
The Why & How
Dr Anil Tarigopula MD, DNB
Senior Consultant,
Apollo Hospitals, Chennai
Is Molecular testing “ESOTERIC”?
Necessary to understand:
1. Target
2. Matrix
3. Method
4. Assay format
Molecular Testing Process
• Requesting molecular analysis
• Preanalytical standards
• Sample receipt and handling
• DNA and RNA extraction
• Choice of analytical method
• Performance of molecular tests
• Reporting molecular diagnostic tests for patients
• QA – internal and external
• Training and expertise
• Research and development
Cree IA, et al. J Clin Pathol 2014; 0:1-9
Polymerase chain reaction
• Molecular Oncology
• Transplantation diagnostics
• Pharmacogenomics
SAMPLE QUALITY
Molecular Oncology
FISH
Mutation status
• Test Validation:
• Analytical validation
• Clinical validation
NGS based Oncology
Diagnostics
• Most of the current CDx- single analyte / pre-specified
mutations
• NGS based testing - numerous biomarkers concurrently
• Simultaneous detection of
• Single nucleotide variants
• Copy number alteration
• Insertions
• Deletions
• Translocations
• Drug repurposing - Application of known/approved drugs to
new indications/cancer type - New target discovery
• Ability to process pooled multiple samples and perform
parallel sequencing, allowing for an appreciable cost
reduction.
PROCESSING
From Specimen To Result: Many Areas of Pre-Analytic Variability
From Specimen To Result: Many Areas of Pre-Analytic Variability
Quality Assurance Program
29